Company / Capital Expenditures
Envista Holdings Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$45.3M
FY2025
5-year range
$33.8M / $75.7M
FY2021-FY2025
Trend
+34.0%
vs FY2024
Sector context
#78 of 145
Health Care
What the data says
At $45M, Envista Holdings's capital expenditures ranks #78 of 145 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $45M.
Based on SEC 10-K filings.
$45M in FY2025 with a 5-year CAGR of -1.0%.
Declined from $58M to $45M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#78 of 145 in Health CareTop 54% of 145This company $45.3M Sector average $268.6M
▼
-83.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, capital expenditures increased 34.0% year-over-year.
- Ranks #78 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.3M | +34.0% |
| FY2024 | $33.8M | -41.9% |
| FY2023 | $58.2M | -23.1% |
| FY2022 | $75.7M | +38.4% |
| FY2021 | $54.7M | +14.7% |
| FY2020 | $47.7M | -38.7% |
| FY2019 | $77.8M | +7.8% |
| FY2018 | $72.2M | +47.6% |
| FY2017 | $48.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026